The global spine market is estimated to grow 5% in 2022 to reach almost $10.500 billion.Today, we are going to make a preliminary market forecast for 2022. In some cases, we take the outlook 2022 published by some companies (Globus Medical or Nuvasive). In others, we are making our estimation. Please, take into account that it is just a preliminary analysis. It is difficult to make a market estimation when the first quarter has not been closed yet.
1.- Medtronic Spine: We consider that in Spine, they will grow in the low single digits between 2-3%.
2.-Johnson&Johnson Spine: We have seen in the latest years their growth decreasing. In 2022, we think they will grow but not significantly (+1,+2%) with our expected sales of $1.285-1.300 billion.
3.-Stryker expects 2022 organic net sales growth to be in the range of 6% to 8% In Spine, we will estimate a 6% growth that leads us to $1,237 MM.
4.- Nuvasive: They recently released their 2022 outlook with an estimated 5-8% growth. We estimate a 6% that places us at $1,207 MM.
5.- Globus Medical: They recently announced the full year 2022 guidance with expected net sales of $1.025 billion.
6.-Zim Vie is forecasting that its annual revenue will stay flat in 2022.
7.- ATEC anticipated full-year 2022 total revenue of $305 million.
8.-SeaSpine expects full-year 2022 revenue to be in the range of $226 to $230 million, reflecting growth of approximately 18% to 20% over full-year 2021.
